DAVID FARMER: Open Payments
NPI 1619985041 · LOCUST GROVE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 12 payments from 9 companies in 2025. Trend: 2023 $1,711 · 2024 $1,639 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
| Lundbeck LLC | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: REXULTI, Ozempic, ZEPBOUND, Sunosi, NURTEC ODT, Wegovy, Dexcom G6 Transmitter, Auvelity.
Industry payments across GA — which companies pay providers there.
